Robotic Vascular Leader Target hospitals and KOLs investing in robotic-assisted vascular interventions. Corindus is a Siemens Healthineers company with a proven platform (CorPath GRX) that expands procedural capabilities, offering potential sales opportunities through IDNs and high-volume cardiovascular centers seeking precision and workflow improvements.

Expansion via Siemens Leverage the Siemens Healthineers relationship to approach accounts already aligned with Siemens ecosystem. Propose integrated solutions, cross-sell compatible devices, and explore service contracts that benefit from Siemens-backed support and global distribution.

TechnIQ Growth Capitalize on the technIQ Series automated movements to showcase workflow efficiency and reproducibility. Market the automation enhancements as a path to reduce procedure times and improve consistency, appealing to centers aiming for standardization and training savings.

Global Robotic Interest Position CorPath GRX as a differentiator in emerging markets and mid-to-large hospitals seeking advanced robotics. Highlight ongoing innovations and potential accelerated adoption through trials, clinical evidence, and global case studies facilitated by Corindus’ expanding tech stack.

Financial Upsell Pathways Identify opportunities for multi-year procurement, service agreements, and training packages. With a substantial funding background and ongoing upgrades, offer bundled financing, lifecycle services, and education programs to drive renewals and add-on modules for robotic procedures.